Recombinant Human Erythropoietin Alfa Injection bulk supplier for pharma manufacturers

Recombinant Human Erythropoietin Alfa Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 2000 IU,3000 IU,4000 IU,5000 IU,6000 IU,10,000 IU & 40,000 IU

Reference Brands: Epogen, Procrit(US), Eprex(EU)

Recombinant Human Erythropoietin Alfa Injection is used to treat anemia in CKD and cancer patients. Marketed as Epogen®, Procrit® (US) and Eprex® (EU), it boosts red blood cell production and reduces transfusion needs in nephrology and oncology care.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Recombinant Human Erythropoietin Alfa Injection is a biologic therapy used to treat anemia associated with chronic kidney disease (CKD), cancer chemotherapy, and HIV treatment. It stimulates red blood cell production, reducing the need for blood transfusions. Commonly marketed as Epogen® and Procrit® in the US, and Eprex® in the EU, Erythropoietin Alfa is a vital medication in nephrology and oncology care. Available in prefilled syringes and vials, it comes in strengths ranging from 2,000 IU to 10,000 IU. Collaborate with WHO-GMP/EU-GMP certified manufacturers to supply high-quality erythropoietin injections for global Pharma B2B markets.

Recombinant Human Erythropoietin Alfa Injection — third party manufacturing & bulk supply

Recombinant Human Erythropoietin Alfa Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Recombinant Human Erythropoietin Alfa Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Recombinant Human Erythropoietin Alfa Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Recombinant Human Erythropoietin Alfa In... →

Back to Listing

Frequently Asked Questions

Recombinant Human Erythropoietin Alfa Injection is listed as Injection in 2000 IU,3000 IU,4000 IU,5000 IU,6000 IU,10,000 IU & 40,000 IU. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Recombinant Human Erythropoietin Alfa Injection is referenced against Epogen, Procrit(US), Eprex(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.